Security key
363225202
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 3,890
- Total 13F value
- $18,050
- Share change
- -704
- SEC-reported price per share
- $4.64
- Number of holders
- 1
- Value change
- -$3,267
- Number of sells
- 1
Report period
Q2 2026
Institutions
1
Top holders
1
GALT full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
GALECTIN THERAPEUTICS INC SEC filings
GALECTIN THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 363225202
Recent filing periods:
Ownership snapshot
Top reported holders of GALT - GALECTIN THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
10X Fund, L.P.
Disclosed value leader
10X Fund, L.P.
Comparable rows
0/15
Latest evidence
31 Mar 2026
3/4/5
13F
Highest disclosed value: $37,392,283
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
10X Fund, L.P. has the largest disclosed position value at $37.39M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 10X Fund, L.P.'s linked filing trail.
Disclosed position value
Top 5
10X Fund, L.P.
$37.39M
Richard E. Uihlein
$31.53M
James C. Czirr
$1.16M
VANGUARD CAPITAL MANAGEMENT LLC
$5.49M
MARSHALL WACE, LLP
$3.4M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 10X Fund, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$37,392,283
5,614,457 shares
|
-$1,581,991 | 02 Dec 2025 |
| Richard E. Uihlein |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$31,526,608
10,420,386 shares
mixed-class rows
|
— | 16 Jan 2026 |
| James C. Czirr |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,160,550
1,045,541 shares
|
— | 03 Feb 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$5,486,652
1,966,542 shares
|
— | 31 Mar 2026 |
| MARSHALL WACE, LLP |
13F
Company
|
—
class O/S missing
|
$3,403,554
1,219,912 shares
|
— | 31 Mar 2026 |
| Joel Lewis |
3/4/5
President and CEO, Director
|
—
mixed-class rows
|
$3,213,845
969,260 shares
mixed-class rows
|
-$709,585 | 16 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
3,890
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
98
Q2 2026 holders
1
Holder diff
-97
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend